Red Clover
Red Clover Extract
A plant rich in isoflavones traditionally used for menopausal symptoms, bone health, and cardiovascular support.
Red Clover (Trifolium pratense) is a flowering plant rich in isoflavones, particularly genistein, daidzein, formononetin, and biochanin A. These compounds have weak estrogenic activity, making red clover popular for managing menopausal symptoms like hot flashes. Research also suggests potential benefits for bone health and cardiovascular function through its effects on lipid profiles and arterial flexibility.
Mechanisms of Action
Phytoestrogen Activity
Binds to estrogen receptors with weak estrogenic effects
Bone Health Support
May slow bone loss through estrogenic effects
Cardiovascular Protection
May improve arterial flexibility and lipid profiles
Recommended Dose
40-80mg isoflavones daily
Loading: Not required; start with lower dose
Optimal Timing
- With meals
- Consistent daily timing
Take with food
Best Form
Standardized extract (40mg isoflavones per dose)
Alternatives: Dried herb capsules, Promensil (branded extract)
Standardized extracts provide consistent isoflavone levels. Promensil is a well-researched branded form.
Duration
Minimum: 8 weeks
Optimal: 24 weeks
Cycling: Not required
Note: Doses typically standardized to isoflavone content (40-80mg). May take 4-12 weeks to see full effects on menopausal symptoms.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Reduced Hot Flashes
Fewer and less intense hot flashes
Bone Density Support
May help maintain bone density
Improved Lipid Profile
Modest improvements in cholesterol
Estrogenic Activity
May affect hormone-sensitive conditions
Avoid due to estrogenic effects
Primary target population; consult physician
Who Should NOT Take This
- Hormone-sensitive cancers (breast, ovarian, uterine)
- History of endometriosis
- History of blood clots
- Hormone Sensitive Cancers - use with caution
Drug Interactions
Additive estrogenic effects
May interfere with anti-estrogen effects
May have anticoagulant effects ā may affect platelet aggregation or vitamin K-dependent clotting factors, altering anticoagulant efficacy
Possible Side Effects
Tip: Reduce dose
Tip: May resolve with continued use
Tip: Take with food
Warnings
- Not for those with hormone-sensitive conditions
- Consult physician before use, especially with history of cancer
Top studies from 40+ peer-reviewed papers
Zuo X et al. ā¢ Nutrients (2023)
āThis study has been registered on PROSPERO (registration number: CRD42022360504).ā
Key Findings:
- A daily intake of 26.7 g of tofu reduced CVDs risk by 18% (TRR = 0.82, 95% CI: 0.74-0.92) and 11.1 g of natto lowered the risk of CVDs by 17% (TRR = 0.83, 95% CI: 0.78-0.89), especially stroke.
- This meta-analysis demonstrated that soy consumption was negatively associated with the risks of T2D and CVDs and a specific quantity of soy products was the most beneficial for the prevention of T2D and CVDs.
- This study has been registered on PROSPERO (registration number: CRD42022360504).
Akhlaghi M et al. ā¢ Critical reviews in food science and nutrition (2020)
āSoy isoflavones prevent osteoporosis-related bone loss in any weight status or treatment duration.ā
Key Findings:
- Soy isoflavones prevent osteoporosis-related bone loss in any weight status or treatment duration.
- They increase BMD in normal weight subjects and diminish bone resorption in overweight/obese individuals.
- Although bone resorption may be decelerated over short-term isoflavone consumption, periods longer than a year are probably needed to affect BMD.
- Isoflavones also appear benefits on bone in any dose or subjects' ethnicity.
Viscardi G et al. ā¢ Advances in nutrition (Bethesda, Md.) (2025)
āAll rights reserved.ā
Key Findings:
- Addressing public health concerns may promote soy foods as high-quality plant protein sources with low environmental impact and cost, particularly benefiting postmenopausal women and aligning with sustainable dietary patterns and guidelines.
- This study was registered in PROSPERO as CRD42023439239.Copyright Ā© 2024 The Author(s).
- Published by Elsevier Inc.
- All rights reserved.
Luan H et al. ā¢ PeerJ (2025)
āMore trials should be conducted in the future to validate our findings.Ā©2025 Luan et al.ā
Key Findings:
- In October 2024, we screened 2,099 articles, of which 12 were eligible for meta-analysis, and found that soy isoflavones were effective for treating menopausal symptoms (seven studies, 533 participants, Hedges' g = -0.25, 95% CI [-0.42 to -0.08], pĀ =Ā 0.00).
- However, our results should be interpreted with caution owing to the small sample size.
- More trials should be conducted in the future to validate our findings.Ā©2025 Luan et al.
Zhao G et al. ā¢ Reproductive biology and endocrinology : RB&E (2025)
āChromium, inositol, and Omega-3 were found to be beneficial for improving lipid profile.ā
Key Findings:
- Inositol significantly decreased total cholesterol and triglyceride levels, while curcumin was most effective in improving low-density and high-density lipoprotein cholesterol levels.
- Chromium, inositol, and Omega-3 were found to be beneficial for improving lipid profile.
- For improving obesity, sex hormone levels, inflammatory factors and oxidative stress indicators of PCOS patients, carnitine, chromium, and soy isoflavones are effective options, respectively.
- These findings confirm that nutritional supplements can effectively alleviate PCOS symptoms, potentially providing valuable guidance for the clinical selection of appropriate nutritional interventions.
Study Type Distribution
Goals This Supplement Supports
Related Goals
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.